4//SEC Filing
CAVANAUGH JAMES H 4
Accession 0001104659-22-097623
CIK 0001509745other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 9:41 PM ET
Size
5.6 KB
Accession
0001104659-22-097623
Insider Transaction Report
Form 4
CAVANAUGH JAMES H
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-01+25,000→ 25,000 totalExercise: $1.43Exp: 2032-08-31→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001013473
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 9:41 PM ET
- Size
- 5.6 KB